BEIJING (Reuters) – China’s total settlement of COVID-19 vaccine expenses from its medical insurance fund nationwide was more than 150 billion yuan ($21.55 billion) in 2021-22, the National Healthcare Security Administration said in a statement on Thursday.
The health insurance fund paid PCR testing expenses worth 4.3 billion yuan in 2022, the administration said.
($1 = 6.9601 Chinese yuan renminbi)
(Reporting by Bernard Orr and Ethan Wang; Editing by Bernadette Baum)
